CN114134239A - Kit for rapidly evaluating mammalian cell quality by PCR (polymerase chain reaction) method and detection method thereof - Google Patents
Kit for rapidly evaluating mammalian cell quality by PCR (polymerase chain reaction) method and detection method thereof Download PDFInfo
- Publication number
- CN114134239A CN114134239A CN202111417378.8A CN202111417378A CN114134239A CN 114134239 A CN114134239 A CN 114134239A CN 202111417378 A CN202111417378 A CN 202111417378A CN 114134239 A CN114134239 A CN 114134239A
- Authority
- CN
- China
- Prior art keywords
- cell
- cells
- pcr
- kit
- detection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 75
- 238000000034 method Methods 0.000 title claims abstract description 37
- 210000004962 mammalian cell Anatomy 0.000 title claims description 6
- 238000003752 polymerase chain reaction Methods 0.000 title description 33
- 241000124008 Mammalia Species 0.000 claims abstract description 5
- 239000002773 nucleotide Substances 0.000 claims abstract description 5
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 5
- 210000004027 cell Anatomy 0.000 claims description 96
- 238000006243 chemical reaction Methods 0.000 claims description 11
- 238000000137 annealing Methods 0.000 claims description 9
- 238000012257 pre-denaturation Methods 0.000 claims description 7
- 239000000872 buffer Substances 0.000 claims description 5
- 238000004925 denaturation Methods 0.000 claims description 5
- 230000036425 denaturation Effects 0.000 claims description 5
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 4
- 238000010561 standard procedure Methods 0.000 claims description 4
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 3
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 3
- 101100172879 Caenorhabditis elegans sec-5 gene Proteins 0.000 claims description 2
- 238000006911 enzymatic reaction Methods 0.000 claims description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 2
- 239000011535 reaction buffer Substances 0.000 claims description 2
- 241000204031 Mycoplasma Species 0.000 abstract description 28
- 241000894007 species Species 0.000 abstract description 15
- 241000894006 Bacteria Species 0.000 abstract description 9
- 239000012634 fragment Substances 0.000 abstract description 7
- 206010011409 Cross infection Diseases 0.000 abstract description 5
- 206010029803 Nosocomial infection Diseases 0.000 abstract description 5
- 230000010261 cell growth Effects 0.000 abstract description 4
- 108020004414 DNA Proteins 0.000 description 23
- 238000011109 contamination Methods 0.000 description 20
- 238000012864 cross contamination Methods 0.000 description 20
- 108010017842 Telomerase Proteins 0.000 description 19
- 230000003321 amplification Effects 0.000 description 18
- 238000003199 nucleic acid amplification method Methods 0.000 description 18
- 239000000047 product Substances 0.000 description 13
- 239000000523 sample Substances 0.000 description 13
- 108091035539 telomere Proteins 0.000 description 13
- 102000055501 telomere Human genes 0.000 description 13
- 230000000694 effects Effects 0.000 description 12
- 210000003411 telomere Anatomy 0.000 description 12
- 241000204003 Mycoplasmatales Species 0.000 description 10
- 238000003205 genotyping method Methods 0.000 description 10
- 239000007850 fluorescent dye Substances 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 230000001580 bacterial effect Effects 0.000 description 8
- 230000035945 sensitivity Effects 0.000 description 8
- 108010044467 Isoenzymes Proteins 0.000 description 6
- 238000003556 assay Methods 0.000 description 6
- 238000004113 cell culture Methods 0.000 description 6
- 238000003125 immunofluorescent labeling Methods 0.000 description 6
- 239000003550 marker Substances 0.000 description 6
- 238000012163 sequencing technique Methods 0.000 description 6
- 241000282414 Homo sapiens Species 0.000 description 5
- 239000000427 antigen Substances 0.000 description 5
- 102000036639 antigens Human genes 0.000 description 5
- 108091007433 antigens Proteins 0.000 description 5
- 210000000349 chromosome Anatomy 0.000 description 5
- 230000012010 growth Effects 0.000 description 5
- 238000003753 real-time PCR Methods 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 238000001228 spectrum Methods 0.000 description 5
- 230000008859 change Effects 0.000 description 4
- 238000012136 culture method Methods 0.000 description 4
- 238000001962 electrophoresis Methods 0.000 description 4
- 230000002068 genetic effect Effects 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 210000005260 human cell Anatomy 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 230000020509 sex determination Effects 0.000 description 4
- 108091081062 Repeated sequence (DNA) Proteins 0.000 description 3
- 239000000443 aerosol Substances 0.000 description 3
- 210000004748 cultured cell Anatomy 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000001502 gel electrophoresis Methods 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000007447 staining method Methods 0.000 description 3
- 230000002194 synthesizing effect Effects 0.000 description 3
- 210000004881 tumor cell Anatomy 0.000 description 3
- 230000000007 visual effect Effects 0.000 description 3
- 102100031126 6-phosphogluconolactonase Human genes 0.000 description 2
- 108010029731 6-phosphogluconolactonase Proteins 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 2
- 102100025287 Cytochrome b Human genes 0.000 description 2
- 108010075028 Cytochromes b Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 108010018962 Glucosephosphate Dehydrogenase Proteins 0.000 description 2
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 2
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 2
- 102000013460 Malate Dehydrogenase Human genes 0.000 description 2
- 108010026217 Malate Dehydrogenase Proteins 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 238000002944 PCR assay Methods 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000032823 cell division Effects 0.000 description 2
- 210000003855 cell nucleus Anatomy 0.000 description 2
- 239000000306 component Substances 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 239000013558 reference substance Substances 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 241000203024 Acholeplasma Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 102000007325 Amelogenin Human genes 0.000 description 1
- 108010007570 Amelogenin Proteins 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000283725 Bos Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- 241000699798 Cricetulus Species 0.000 description 1
- 102000000634 Cytochrome c oxidase subunit IV Human genes 0.000 description 1
- 108090000365 Cytochrome-c oxidases Proteins 0.000 description 1
- 108010052832 Cytochromes Proteins 0.000 description 1
- 102000018832 Cytochromes Human genes 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 241000282553 Macaca Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000204048 Mycoplasma hominis Species 0.000 description 1
- 241000204045 Mycoplasma hyopneumoniae Species 0.000 description 1
- 241000202938 Mycoplasma hyorhinis Species 0.000 description 1
- 241000202894 Mycoplasma orale Species 0.000 description 1
- 241000202934 Mycoplasma pneumoniae Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 102000009097 Phosphorylases Human genes 0.000 description 1
- 108010073135 Phosphorylases Proteins 0.000 description 1
- 102220493065 Protein Flattop_D16S_mutation Human genes 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 101150071661 SLC25A20 gene Proteins 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 241001052560 Thallis Species 0.000 description 1
- 241000202921 Ureaplasma urealyticum Species 0.000 description 1
- 101150003160 X gene Proteins 0.000 description 1
- 101150044453 Y gene Proteins 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 210000004271 bone marrow stromal cell Anatomy 0.000 description 1
- 101150102633 cact gene Proteins 0.000 description 1
- 239000012930 cell culture fluid Substances 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000002659 cell therapy Methods 0.000 description 1
- 230000010094 cellular senescence Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000012533 medium component Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- INAAIJLSXJJHOZ-UHFFFAOYSA-N pibenzimol Chemical compound C1CN(C)CCN1C1=CC=C(N=C(N2)C=3C=C4NC(=NC4=CC=3)C=3C=CC(O)=CC=3)C2=C1 INAAIJLSXJJHOZ-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 108700022487 rRNA Genes Proteins 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 230000009758 senescence Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 210000001082 somatic cell Anatomy 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 239000012798 spherical particle Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000017105 transposition Effects 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6879—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for sex determination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention relates to the field of cell identification, in particular to a kit for rapidly evaluating the cell quality of mammals by a PCR method and a detection method thereof. The kit comprises a nucleotide sequence shown as SEQ ID NO: 1 to 12. The invention selects the fragments with higher conservation in the types of the general possibly polluted cells as the primers, can detect the cell species and types, has short detection time, can quickly obtain the result, can obtain the accurate infected bacteria, mycoplasma, cell growth quality or cell cross infection type and sex, is convenient for subsequent experimental treatment or protection, has wide detection range, can detect a plurality of types of the possibly polluted cells, reduces the possibility of pollution or false positive, and can comprehensively identify the cell line.
Description
Technical Field
The invention relates to the field of cell identification, in particular to a kit for rapidly evaluating the cell quality of mammals by a PCR method and a detection method thereof.
Background
Cells cultured in vitro are increasingly used in scientific research and production. Meanwhile, the use of cross-contaminated cells is getting more and more serious, and the quality of scientific research and the quality of products are seriously influenced. In addition to research, cultured cells are also used for disease diagnosis and production of bioactive substances, and the quality of the cells is particularly important. Therefore, the method attracts the attention of students and puts forward quality requirements. The cell lines currently being proposed for research need to be fully characterized.
The core problems existing in the use of the in vitro cultured cells are: pathogens, microbial contamination, cell cross-contamination or identification errors, and genetic information changes due to over-passaging of cells. The reasons for these changes are mainly: cell culture procedures are not standard, cell sources are not clear, passage numbers are not clear, introduced cell errors, and the like.
Mycoplasma contamination is a problem that is easy to occur, difficult to avoid and difficult to find in the cell culture process. When cells (particularly subcultured cells) are contaminated with mycoplasma, the expression of DNA, RNA and protein in the cells is changed, and the growth rate of the cells is generally not significantly influenced, so that the contamination of the cells with mycoplasma is generally difficult to detect.
Mycoplasma detection generally employs several methods:
1. the culture method comprises the following steps: the method is characterized by comprising the following steps of placing a cell culture in a mycoplasma broth liquid culture medium, culturing at 37 ℃ for 3 days, centrifuging, transferring a precipitate into a mycoplasma solid agar culture medium, culturing under the same condition, and observing that if a similar fried egg-like bacterial colony appears in the culture medium, the cell is polluted by the mycoplasma.
DNA fluorescent staining method: cells and mycoplasma DNA are marked by using a fluorescent reagent Hoechst 33258 and the like, a fluorescent dye is combined to an A-T enrichment area of the DNA, the mycoplasma DNA can be dyed because the A-T content is most, the dye generates yellow green fluorescence under the excitation of ultraviolet light, and whether the mycoplasma exists is observed by using a fluorescence microscope. The normal nucleus region shows fluorescence with clear and regular edges, and the cytoplasm region does not show fluorescence. The mycoplasma contaminated cells can see many fluorescent dots with uniform size on the cell nucleus, the outside of the cell nucleus and the cell membrane, namely mycoplasma DNA, and the mycoplasma contaminated cells are proved.
Method for detecting Mycoplasma by PCR (polymerase Chain reaction): the rRNA gene of mycoplasma, a prokaryotic organism, is formed by interval arrangement of conserved and multiple-variant sequences and can be used as an index for biological classification. PCR uses 4 dNTPs as substrates, and performs extension of a complementary strand at the 3' end of a DNA template in the presence of a primer, and can exponentially amplify a trace amount of template nucleic acid through repeated cycles. The PCR detection method is particularly suitable for detection and identification of mycoplasma which are difficult to culture and time-consuming.
4. A fluorescent quantitative PCR method: the fluorescent quantitative PCR is realized by adding a fluorescent probe or a corresponding fluorescent dye on the basis of the conventional PCR. As the PCR reaction proceeds, the PCR reaction products are accumulated continuously, and the intensity of the fluorescence signal is increased in equal proportion. After each cycle, the fluorescence signal is collected, so that the change of the product amount can be monitored through the change of the fluorescence intensity, and a fluorescence amplification curve is obtained. The Ct value in real-time fluorescent quantitative PCR technology refers to the number of cycles that the fluorescent signal in each reaction tube undergoes when it reaches a set threshold. The Ct value of each template has a linear relation with the logarithm of the initial copy number of the template, and the more the initial copy number is, the smaller the Ct value is. A standard curve can be made using a standard with a known starting copy number, where the abscissa represents the logarithm of the starting copy number and the ordinate represents the Ct value. Therefore, once the Ct value of an unknown sample is obtained, the initial copy number of the sample can be calculated from the standard curve.
Bacterial contamination is a common contamination in laboratory cell cultures. Attention is paid to prevent pollution from beginning, otherwise, the pollution can be abandoned, time is wasted, manpower and material resources are wasted, and even loss which cannot be compensated is caused. Even if antibiotics (generally in prophylactic doses) are added to the cell culture fluid, contamination can result from inadvertent handling. The most common are gram-positive bacteria such as Bacillus subtilis, and gram-negative bacteria such as Escherichia coli and Pseudomonas, and the most common is Staphylococcus albus.
After the cultured cells are contaminated by bacteria, the culture solution becomes turbid, and the pH changes to become yellow. The visual observation of some culture solutions has little change, and the contamination can only be known by the thalli found under a mirror. Therefore, careful observation should be made every day. After pollution, cells are pathologically changed, and intracellular particles are increased and thickened, and finally become round and fall off to die, so that test failure and cell strain (line) loss are caused. Bacterial contamination generally progresses rapidly and can be observed visually after about one or two days. Bacteria detection generally employs several methods:
1. and (4) visual observation: bacterial and fungal contamination often occurs after open operations such as passage, liquid change, sample addition and the like, and proliferation is rapid, and if contamination exists, the contamination can be obviously observed within 48 hours.
2. And (3) inoculation observation: contamination can also be detected by inoculating with a normal broth or by inoculating with a culture medium without the double-resistant drug.
3. And (3) observing under a microscope: a large amount of spherical particles in the culture solution can be seen to float under a high power microscope of an inverted microscope, namely bacterial pollution is obtained; if there are filamentous, tubular, dendritic or ovoid material between the cells, fungal contamination is common.
4. Sequencing and verifying: taking a proper amount of culture solution to extract genome and sequencing, and then analyzing a sequencing result.
Cell cross-infection detection generally employs several methods:
cell culture procedures are not technically standardized, cell sources are not clear, passage numbers are not clear, introduced cells misuse cross-contaminated or misidentified cells resulting in erroneous findings, unrepeatable results, catastrophic consequences of clinical cell therapy, which wastes a lot of time, effort and money.
Therefore, in recent years, NIH, ATCC, Nature, Science and the like have called for many times, researchers are required to identify cells, and for example, 2011 the national standard institute of the national standards of cell STR identification has specially issued; journal of Science of 12 months in 2014 and 2 months in 2015 respectively issues a special article to illustrate the severity of cell cross contamination and misidentification; nature notification of month 4 in 2015: nature J.Gen.will require the authors, starting from month 5, to identify the cell lines used in the paper; in 2015, 6 months, it was reported that a scientist withdrawn the Nature paper due to the use of wrong cell lines.
1. Isozyme spectrum detection method: because cells from different species have difference in isozyme spectrum distribution, after separation by gel electrophoresis, the electrophoresis band type and the relative migration distance are detected, and the method can be used for detecting cell cross contamination. The isozyme spectrum detection method is suitable for detecting cross contamination of cells among species. When the isozyme spectrum detection method is adopted to detect the cross contamination of cells, the detection of glucose-6-phosphate dehydrogenase (G6PD), Lactate Dehydrogenase (LDH), Malate Dehydrogenase (MD) and Nuclear Phosphorylase (NP) is very important. If the isozyme mobility of the cell sample to be detected is inconsistent with that of the standard reference substance or a plurality of zymogram bands exist, the cell sample can be judged to have intergeneric cell cross contamination.
HLA genotyping assay: since HLA is a stable genetic marker that is most representative of individual specificity due to its high polymorphism and that accompanies the life of an individual, the probability that HLA types are identical between unrelated individuals is extremely low, and thus, the presence or absence of cross contamination of cells can be determined by detecting the HLA genotype of the cells. Since the HLA genotype exists only in human body, the HLA genotyping detection method is suitable for the detection of cross contamination between different human cells (within species). The HLA genotype detection method preferably adopts sequence specific primers for PCR amplification and combines with the second generation sequencing technology for HLA high-resolution typing detection. If the HLA genotyping result of the cell sample to be detected is obviously different from that of the target cell, the existence of cell cross contamination in the species of the human cells can be judged.
3. And (3) cell morphology analysis: the cell morphology detection method generally detects the characteristics of cell growth morphology, growth characteristics and the like, and preliminarily judges whether cell cross contamination occurs. The cell morphology detection method is suitable for detecting cross contamination of cells growing in an adherent manner, and is not suitable for cells growing in a suspension manner. The detection indexes of the cell morphology detection method generally comprise cell morphology (such as round shape, fusiform shape and the like), cell diameter and cell volume. Due to the low detection accuracy, if the cells are detected to be possibly cross-contaminated by a cell morphology detection method, the selection of other detection methods for further verification and confirmation is very important.
PCR assay: the PCR detection method is a cell cross-contamination detection method established based on evolutionary conservative differences among species, and has high sensitivity and specificity. At present, conserved genes such as cytochrome b (CYTB) and cytochrome c oxidase 1(cytochrome coxasebunit 1, Col) have large differences between different species, and have been used for detection of cell cross contamination. The PCR detection method is mainly suitable for detecting cross contamination of cells among species at present.
STR genotyping assay: the STR genotyping detection method is characterized in that an STR map is obtained by simultaneously amplifying and detecting a plurality of STR loci according to the polymorphism of cells from different individual sources at STR loci, whether the cells have cross contamination or not is detected, and the STR genotyping detection method has the characteristics of high sensitivity, high identification capability, standardized automatic typing and the like. The STR genotyping detection method is suitable for detecting cross contamination of cells in species. When the STR genotyping detection method is used for detecting the cross contamination of the human cells, the detected STR loci preferably comprise: D13S317, TH01, D5S818, D16S 53: TPOX, D7S820, CSF 1PO, vWA and sex determination site Amelogenin (AMEIJ).
6. Immunofluorescence staining assay: some cells have specific antigen or receptor markers (such as specific proteins), and the immunofluorescent staining detection method can observe and detect the biological characteristics of the cells under a fluorescent microscope after the fluorescent pigment which does not influence the activity of antigen antibodies is marked on the antibodies (or antigens) and is combined with the corresponding antigens (or antibodies). The immunofluorescence staining detection method is suitable for detecting the special characteristics of cells; part of the species cells have specific antibodies, and the immunofluorescence staining is also suitable for detecting cross contamination of part of the intergeneric cells. When performing immunofluorescence staining detection, selecting an antigen or receptor marker with typicality and specificity is very important for effectively identifying the specific characteristics of cells.
However, the above detection is not complete, and it is necessary to determine by the experience of the operator which contamination is to be detected by selecting the corresponding method. In addition, various experimental methods have corresponding disadvantages.
And (3) detecting telomerase:
telomerase is an enzyme that synthesizes telomeres at the ends of chromosomes. Telomeres (telomere) are natural ends of chromosomes of eukaryotic cells, are composed of thousands of 6-base repeat sequences (TTAGGG), are essential genetic components of the cells, and have the function of maintaining the telomeres to have enough length and ensuring the accuracy of gene information in a replication process so as to prevent the loss of genetic information at the ends of the chromosomes. Under normal conditions, the telomeres become shorter and shorter in each cell division cycle, and when the telomeres are short to a certain extent, a signal is sent out, and the cell division is stopped. The number of passages is large, and telomeres are shortened due to poor cell growth state. In the process of cell chromosome replication, self RNA is taken as a template, and a repetitive sequence is synthesized at the 3' end of a chromosome to maintain the length of telomeres. Telomerase activity is inhibited in normal somatic cells, but extensive data indicate expression in some malignancies as high as 85%. Because telomerase is specifically expressed in a variety of tumor cells and is required for the continued division of most tumor cells.
The basic principle is as follows: by using the characteristic that telomerase can take the template region of RNA of the telomerase as a template in vitro and adds a 6-base repeated sequence at the tail end of an appropriate oligonucleotide chain, the repeated sequence is amplified by adopting a PCR method, and then a ladder band with 6 base differences is displayed by agarose electrophoresis. The TRAP method established by Kim in 1994 has the following main principles: firstly, synthesizing 18nt TS as an upstream primer, combining telomerase with GTT at the end of TS and synthesizing AGGGTTAG, then synthesizing a 6-base repeat sequence of ggttag by transposition once, after inactivating the telomerase, adding CX as a downstream primer, and amplifying a telomerase extension product by multiple times of denaturation, annealing and extension. The PCR telomerase activity detection kit detects the activity of telomerase based on the same principle. Positive results show ladder-like bands separated by 6bp on gel electrophoresis, and the more, less, darker or lighter bands indicate the activity of telomerase. The advantages of high sensitivity, strong specificity and the like of the traditional TRAP method are reserved. Meanwhile, an internal standard substance is added to provide a positive reference substance, the design of a primer is optimized, the PCR effect is further improved, and the activity of telomerase in cell and tissue extracts can be detected with high sensitivity.
And (3) detection of mycoplasma:
1. the culture method is simple and intuitive, most mycoplasma can generate special typical colonies, but the growth of the mycoplasma is slow, about 3-4 hours is needed for one-generation culture, 28 days of culture is generally needed for judging whether the mycoplasma is polluted, the workload is large, and the risk of further expanding the spread of the mycoplasma is caused. The mycoplasma is harsh on culture conditions, the normal growth of the mycoplasma is affected by different medium component qualities or batches, and some mycoplasma cannot grow by a culture method, so the detection result by using the culture method is not accurate, and false negative is easily generated.
And 2, the DNA fluorescent staining sensitivity is low, and the mild mycoplasma pollution of the cells is difficult to detect due to the existence of background fluorescence. Debris from cell lysis death can also be mistaken for mycoplasma staining by fluorescent staining resulting in false positives. The DNA fluorescent staining method shortens the detection time compared with the cell culture method, but has low sensitivity and accuracy and needs a fluorescent microscope for detection. The fluorescent staining method cannot determine which mycoplasma caused the contamination of cells in particular. Fluorescent staining generally requires the culture of non-contaminating indicator cells as controls, increasing the detection effort.
3. Because of the large copy number of PCR products, a very small amount of contamination can cause false positives. The most likely form of contamination of the PCR product is aerosol contamination, which can occur when the reaction tube is shaken vigorously during handling, especially when the reaction tube is opened for electrophoretic spotting. An aerosol particle contains a large number of copies, so that false positives due to contamination by aerosol are a particular concern, and PCR can only detect one indicator at a time.
4. The real-time fluorescent quantitative PCR needs to be matched with a fluorescent quantitative PCR instrument with high price, the equipment maintenance cost is high, the machine setting operation is complex, professional personnel are needed, and the comprehensive popularization is difficult.
STR spectrum analysis method is only suitable for the intraspecific cell identification and cross contamination detection of cells of few species of human and mouse sources.
And (3) detecting bacteria:
1. and (4) visual observation: the method is not objective and accurate enough and is easy to misjudge.
2. And (3) inoculation observation: the culture conditions and operation requirements are high, and the aseptic operation needs to be strictly maintained. Therefore, other strains are easily infected in the operation process, and the result is misjudged.
3. And (4) microscopic observation: the microscopic observation may cause a deviation in the judgment of the result. The method is not rigorous and effective because it cannot accurately judge whether the infected cells are bacteria or not, and no other reason is available.
4. Sequencing and verifying: the requirements for laboratory equipment and technology are high, professional equipment is needed, and the operation is complex.
And (3) detecting cell cross infection:
1. isozyme spectrum detection method: subjective judgment may affect the judgment of the result, and no objective data exists. The sensitivity is low.
HLA genotyping assay: and the requirement on typing and identification is high.
3. And (3) cell morphology analysis: suspension cells cannot be detected, and the accuracy is low.
PCR assay: the experimental equipment is high in cost, and the experiment is relatively complex to carry out.
STR genotyping assay: at present, the method is only suitable for detecting the cross infection of human cells.
6. Immunofluorescence staining assay: non-specific staining affects detection sensitivity.
The growth quality of the cells is as follows:
the mechanism of cellular senescence has not been completely elucidated so far. Since most immortalized and tumor cells highly express telomerase activity, it is presently believed that changes in telomere length may be a molecular biological clock of cell division and senescence.
Therefore, the detection method has the defects that the detection time is too long, the detection cannot be simultaneously performed on infected mycoplasma, bacteria, cell types and cell algebra accurately and qualitatively, the detection cannot be performed on multiple types, the common detection is single, the single detection range is narrow, the cell types cannot be detected, the observed result cannot be judged only by subjectivity, and objective data are needed to support the experimental result.
Disclosure of Invention
The invention aims to overcome the defects of the prior art and provides a kit for rapidly evaluating the cell quality of mammals by a PCR method and a detection method thereof.
In order to achieve the purpose, the invention adopts the technical scheme that: provides a kit for rapidly evaluating the cell quality of mammals by a PCR method, wherein the kit comprises a nucleotide sequence shown as SEQ ID NO: 1 to 12.
As a preferred embodiment of the kit of the present invention, the kit further comprises Taq Pro Multiplex DNA polymerase.
In a preferred embodiment of the kit of the present invention, the kit further comprises a2 × Multiplex buffer.
In a preferred embodiment of the kit of the present invention, the 2 × Multiplex buffer comprises: enzyme reaction buffer, 2mM dNTPs and 25mM MgSO4。
The invention also provides a detection method for rapidly evaluating the quality of the mammalian cells by a PCR method, wherein the detection method adopts a nucleotide sequence shown as SEQ ID NO: 1-12, and carrying out PCR detection.
As a preferred embodiment of the detection method of the present invention, the PCR reaction may employ standard procedures under the following conditions: pre-denaturation at 95 ℃ for 30 sec-5 min; denaturation at 95 ℃ for 30 sec; annealing at 60 ℃ for 90 sec; extension 72 ℃ 60 sec; completely extending at 72 ℃ for 10 min; the number of cycles: 30-34.
As a preferred embodiment of the detection method of the present invention, the PCR reaction can be performed by a rapid procedure under the following conditions: pre-denaturation at 95 ℃ for 30 sec; denaturation at 95 ℃ for 15 sec; annealing at 60 ℃ for 30 sec; extension 72 ℃ 30 sec; completely extending at 72 ℃ for 5 min; the number of cycles: 25-30.
The invention has the beneficial effects that:
1. the detection time is short, and the result can be obtained quickly;
2. the cross infection type or cell growth condition (telomere length) and sex of the infected bacteria, mycoplasma or cells can be accurately obtained, and the subsequent experimental treatment or protection is convenient;
3. the kit is designed, and the experimental detection is simple and convenient;
4. the detection range is wide, and a plurality of types of possibly polluted cells can be detected;
5. reducing the likelihood of contamination or false positives;
6. selecting a fragment with high conservation in types which are generally possible to pollute cells as a primer;
7. cell species and type can be detected (optionally with sex determination primers).
Drawings
FIG. 1 is a graph showing the results of detection of Mycoplasma; m: DNA2000 Marker; 1: PK-15 cell positive control; 2: a Hela cell positive control; 3: BMSCs; 4-5: THP-1 cells; 6: complete culture solution for culturing THP-1 cells; 7: hyclone 1640 medium; 8: hyclone australian fetal bovine serum; 9: blank control.
FIG. 2 is a 1.5% agarose electrophoresis chart of the results of bacterial detection; lane M: DL2000 DNA Marker; lane 1: sample amplification products; lane 2: a positive control amplification product; lane 3: negative control amplification products; lane M: DL2000 DNA Marker.
FIG. 3 is a diagram showing identification of sample species; m: and (5) Marker. The sizes from top to bottom are 700, 600, 500, 400, 300, 200 and 100bp, respectively. 1484: no band was detected, which was not one of the nine species we tested (Homo sapiens 391bp, Cricetulus griseus315bp, Macaca mulatta287bp, Cercopticitech aethiops222bp, Rattus norvegicus196bp, Canis familiaris172bp, Mus mululus 150bp, Bos Taurus102bp, IC 70 bp). 1485: the sample is temporarily human.
FIG. 4 is a diagram showing the results of telomere length measurement of cells.
FIG. 5 is a diagram of the positions of primers.
FIG. 6 is a sex determination electrophoretogram.
Detailed Description
To more clearly illustrate the technical solutions of the present invention, the following embodiments are further described, but the present invention is not limited thereto, and these embodiments are only some examples of the present invention.
Example 1
This example provides a method for rapidly evaluating mammalian cell quality by PCR, and the amplification products of the primers selected by the invention are:
the primer sequences used were:
detection method
The culture supernatant of THP-1 cells was aspirated and added to the PCR reaction system. The enzyme used was Taq Pro Multiplex DNA polymerase from Toyobo. The PCR reaction system comprises the following components in percentage by weight: 2 × Multiplex buffer; the PCR reaction conditions are shown in the following table:
standard procedures:
quick program:
note:
a. in many cases, a default annealing temperature may be used. If the amplification effect is not good, the optimal annealing temperature can be found through an annealing temperature gradient experiment; rapid procedures lose part of the amplification yield, and standard procedures are recommended for primary amplification.
b. The pre-denaturation time can be adjusted for different template types. (ii) extracted nucleic acid, with a pre-denaturation time of 30 sec; in the case of direct amplification of whole blood, blood card, etc., the pre-denaturation time may be extended to 5 min.
c. When a low copy template, a long fragment or a large number of amplified fragments are amplified, the annealing time can be properly prolonged to 3min to improve the amplification efficiency.
d. The extension time is based on the longest segment. However, an extension time that is too long leads to increased non-specific amplification, and the amplification specificity can be improved by shortening the extension time.
e. When a trace amount of a sample is amplified, the amount of the amplified product can be increased by increasing the number of cycles. However, too many cycles lead to increased non-specific amplification, and the amplification specificity can be improved by reducing the number of amplification cycles.
Second, the detection result
(1) The detection result of mycoplasma is shown in fig. 1, the primer sequence adopted by the invention can simultaneously identify 12 mycoplasma, and the amplification size is 261-576 (the following list is used for reference, and the specific content is based on the sequencing result):
mycoplasma hominis: 261
Mycoplasma arthritides: 262
Mycoplasma salivarius: 295
Arginine mycoplasma: 300
Mycoplasma orale: 316
Ureaplasma urealyticum: 300
Fermentation of mycoplasma: 391
Mycoplasma neurolysis: 393
Mycoplasma hyopneumoniae: 250
Mycoplasma hyorhinis: 300
Mycoplasma pneumoniae: 576
Acholeplasma leinii: 400
(2) The results of the bacterial tests are shown in FIG. 2, which indicates whether the sample is contaminated with bacteria. The amplification was performed with 16s primers, with the band sample being bacterial contaminated and not.
(3) The cell cross-contamination results are shown in fig. 3, indicating sample species identification. Human: 391, mice: 150.
(4) detecting the length of telomerase: ladder-like bands separated by 6bp are displayed on gel electrophoresis, and the more, less, deeper or lighter bands indicate the size of telomerase activity.
Kim established a sensitive telomerase detection method, Telomere Repeat Amplification (TRAP), by PCR in 1994. The product is a research kit developed by appropriately improving the method. Compared with the common telomerase activity determination method, the product has the following characteristics:
the telomerase extract is subjected to PCR amplification in the same tube, so that the detection accuracy is improved.
The primer design was optimized to further improve the PCR effect.
(5) The results of sex determination are shown in FIG. 4, which shows that the sex product fragments are of different sizes, the Y gene fragment is 218, and the X gene fragment is 106.
Finally, it should be noted that the above embodiments are only used for illustrating the technical solutions of the present invention and not for limiting the protection scope of the present invention, and although the present invention is described in detail with reference to the preferred embodiments, it should be understood by those skilled in the art that modifications or equivalent substitutions can be made on the technical solutions of the present invention without departing from the spirit and scope of the technical solutions of the present invention.
SEQUENCE LISTING
<110> Guangzhou Ye-Zhi-Biotechnology Co., Ltd
<120> kit for rapidly evaluating mammalian cell quality by PCR method and detection method thereof
<130> 2021.11.24
<160> 12
<170> PatentIn version 3.3
<210> 1
<211> 20
<212> DNA
<213> Artificial sequence
<400> 1
tcgtaacaag gtatccctac 20
<210> 2
<211> 18
<212> DNA
<213> Artificial sequence
<400> 2
gcatccacca aatactct 18
<210> 3
<211> 19
<212> DNA
<213> Artificial sequence
<400> 3
aactggagga aggtgggga 19
<210> 4
<211> 19
<212> DNA
<213> Artificial sequence
<400> 4
aggaggtgat ccaaccgca 19
<210> 5
<211> 23
<212> DNA
<213> Artificial sequence
<400> 5
tagacatcgt actacacgac acg 23
<210> 6
<211> 20
<212> DNA
<213> Artificial sequence
<400> 6
tccaggttta tggagggttc 20
<210> 7
<211> 20
<212> DNA
<213> Artificial sequence
<400> 7
ccagtatgca gtggttcaga 20
<210> 8
<211> 21
<212> DNA
<213> Artificial sequence
<400> 8
ctcgatgaca acagagttcc t 21
<210> 9
<211> 21
<212> DNA
<213> Artificial sequence
<400> 9
acctcatcct gggcaccctg g 21
<210> 10
<211> 20
<212> DNA
<213> Artificial sequence
<400> 10
tccgaactcc ggttggtagt 20
<210> 11
<211> 24
<212> DNA
<213> Artificial sequence
<400> 11
ttctctttac taattttgat cact 24
<210> 12
<211> 24
<212> DNA
<213> Artificial sequence
<400> 12
tagtctcgaa tttgaccctt cgac 24
Claims (7)
1. A kit for rapidly evaluating the cell quality of mammals by a PCR method is characterized by comprising a nucleotide sequence shown as SEQ ID NO: 1 to 12.
2. The kit of claim 1, wherein the kit further comprises Taq Pro Multiplex DNA polymerase.
3. The kit of claim 1, further comprising a2 x Multiplex buffer.
4. The kit of claim 3, wherein the 2 x Multiplex buffer comprises: enzyme reaction buffer, 2mM dNTPs and 25mM MgSO4。
5. A detection method for rapidly evaluating the quality of mammalian cells by a PCR method is characterized in that the detection method adopts a nucleotide sequence shown as SEQ ID NO: 1-12, and carrying out PCR detection.
6. The detection method according to claim 5, wherein the PCR reaction is performed by a standard procedure under the following conditions: pre-denaturation at 95 ℃ for 30 sec-5 min; denaturation at 95 ℃ for 30 sec; annealing at 60 ℃ for 90 sec; extension 72 ℃ 60 sec; completely extending at 72 ℃ for 10 min; the number of cycles: 30-34.
7. The detection method according to claim 5, wherein the PCR reaction is performed by a rapid procedure under the following conditions: pre-denaturation at 95 ℃ for 30 sec; denaturation at 95 ℃ for 15 sec; annealing at 60 ℃ for 30 sec; extension 72 ℃ 30 sec; completely extending at 72 ℃ for 5 min; the number of cycles: 25-30.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111417378.8A CN114134239B (en) | 2021-11-25 | 2021-11-25 | Kit for rapidly evaluating quality of mammalian cells by PCR method and detection method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111417378.8A CN114134239B (en) | 2021-11-25 | 2021-11-25 | Kit for rapidly evaluating quality of mammalian cells by PCR method and detection method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114134239A true CN114134239A (en) | 2022-03-04 |
CN114134239B CN114134239B (en) | 2023-09-15 |
Family
ID=80388241
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111417378.8A Active CN114134239B (en) | 2021-11-25 | 2021-11-25 | Kit for rapidly evaluating quality of mammalian cells by PCR method and detection method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114134239B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116875710A (en) * | 2023-04-14 | 2023-10-13 | 鲲鹏基因(北京)科技有限责任公司 | Construction method of amplification system for identifying mycoplasma and primer probe combination thereof |
CN119662867A (en) * | 2024-12-24 | 2025-03-21 | 舜喜再生医学科技(昆明)有限公司 | Method for detecting common pollution indicator bacteria in MSC (moving picture experts group) preparation |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5837453A (en) * | 1992-05-13 | 1998-11-17 | Geron Corporation | Telomerase activity assays |
US20040265815A1 (en) * | 2001-06-23 | 2004-12-30 | Baird Duncan Martin | Method for determination of telomere length |
CN103614361A (en) * | 2013-08-20 | 2014-03-05 | 无锡中德美联生物技术有限公司 | Kit for multiplex amplification of 24 loci of human genome DNA |
CN107326062A (en) * | 2017-06-26 | 2017-11-07 | 陕西省人民医院 | A kind of appraisal procedure of the umbilical cord mesenchymal stem cells quality of the pharmaceutical preparations |
CN109536634A (en) * | 2019-01-25 | 2019-03-29 | 武汉睿健医药科技有限公司 | Universal primer, kit and the detection method that fungal contamination detects in cell product |
CN112941201A (en) * | 2021-03-01 | 2021-06-11 | 武汉珈创生物技术股份有限公司 | Mixed primer for multi-cell species identification and cross contamination detection and use method thereof |
CN113201489A (en) * | 2021-05-14 | 2021-08-03 | 达瑟儿(上海)生命科技有限公司 | Preparation method of adipose-derived mesenchymal stem cell working cell bank |
-
2021
- 2021-11-25 CN CN202111417378.8A patent/CN114134239B/en active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5837453A (en) * | 1992-05-13 | 1998-11-17 | Geron Corporation | Telomerase activity assays |
US20040265815A1 (en) * | 2001-06-23 | 2004-12-30 | Baird Duncan Martin | Method for determination of telomere length |
CN103614361A (en) * | 2013-08-20 | 2014-03-05 | 无锡中德美联生物技术有限公司 | Kit for multiplex amplification of 24 loci of human genome DNA |
CN107326062A (en) * | 2017-06-26 | 2017-11-07 | 陕西省人民医院 | A kind of appraisal procedure of the umbilical cord mesenchymal stem cells quality of the pharmaceutical preparations |
CN109536634A (en) * | 2019-01-25 | 2019-03-29 | 武汉睿健医药科技有限公司 | Universal primer, kit and the detection method that fungal contamination detects in cell product |
CN112941201A (en) * | 2021-03-01 | 2021-06-11 | 武汉珈创生物技术股份有限公司 | Mixed primer for multi-cell species identification and cross contamination detection and use method thereof |
CN113201489A (en) * | 2021-05-14 | 2021-08-03 | 达瑟儿(上海)生命科技有限公司 | Preparation method of adipose-derived mesenchymal stem cell working cell bank |
Non-Patent Citations (2)
Title |
---|
HYERAN SUNG 等: "PCR-based detection of Mycoplasma species", J MICROBIOL ., vol. 44, no. 1, pages 42 - 49 * |
赵俊;王兴满;胡勇;陈敬贤;王明丽;: "动物细胞培养物中支原体污染的检测", 安徽农业科学, no. 03, pages 1151 - 1153 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116875710A (en) * | 2023-04-14 | 2023-10-13 | 鲲鹏基因(北京)科技有限责任公司 | Construction method of amplification system for identifying mycoplasma and primer probe combination thereof |
CN119662867A (en) * | 2024-12-24 | 2025-03-21 | 舜喜再生医学科技(昆明)有限公司 | Method for detecting common pollution indicator bacteria in MSC (moving picture experts group) preparation |
Also Published As
Publication number | Publication date |
---|---|
CN114134239B (en) | 2023-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113249499B (en) | Salmonella typhi detection kit, and preparation method and application thereof | |
CN109593868B (en) | Characteristic nucleotide sequence for detecting pseudomonas bacteria, and specific primer, kit and detection method thereof | |
CN114134239B (en) | Kit for rapidly evaluating quality of mammalian cells by PCR method and detection method thereof | |
CN110305948A (en) | A reagent and method for detecting the copy number of autism-related gene UBE3A | |
CN114134218B (en) | Fluorescent detection method based on CRISPR-Cas12a | |
CN118109618A (en) | Universal primer for detecting microbial contamination of mesenchymal stem cells and detection method thereof | |
CN110016512A (en) | Multiplex fluorescence quantitative PCR detection kit and method for simultaneous detection of three bovine respiratory pathogens | |
CN106834520B (en) | Kit for identifying bacteria by using molecular beacon-melting curve technology and application thereof | |
CN101974632B (en) | Method for quantitatively detecting toxigenic microcystis and special standard substance thereof | |
CN114790490A (en) | Molecular marker capable of distinguishing Brucella melitensis and detection method | |
CN112176080B (en) | Nested PCR primer set, kit and detection method for specific detection of sisal purple leaf curl phytoplasma | |
CN101974633B (en) | A method for quantitatively detecting Microcystis and its special standard | |
CN109055618A (en) | For detect the specific primer of infectious spleen and kidney necrosis virus to, probe, detection kit | |
CN117844953A (en) | Primers, probes and method for dual fluorescence quantitative PCR detection of Salmonella and Streptococcus dysgalactiae | |
CN117363757A (en) | KASP typing method of bovine non-coding RNA (ADNCR) gene mutation and application thereof | |
CN115029460A (en) | A real-time visual detection method for Haemophilus parasuis | |
CN116121416A (en) | Rapid detection method for simultaneously detecting multiple mycoplasma pollution and confirming mycoplasma species, primer set and kit | |
CN118064616B (en) | Method for rapidly detecting bacterial, fungal and mycoplasma pollution in mesenchymal stem cell culture process based on fluorescence quantitative PCR | |
CN118460744B (en) | A method for detecting Cronobacter malonate based on the MIRA-CRISPR Cas12a system | |
CN117947188B (en) | SNP molecular markers, primers, probe kits and applications related to Brucella streptomycin resistance | |
RU2583924C1 (en) | METHOD FOR MULTIPLEX PCR DETECTION OF Atopobium vaginae, Leptotrichia amnionii, Sneathia sanguinegens AND Eggerthella spp. IN CLINICAL MATERIAL | |
CN113913556B (en) | Kit for rapidly detecting bat adenovirus and detection method thereof | |
TWI692528B (en) | Methods for detecting E. coli and molecular markers used | |
CN108118097B (en) | Primer probe, kit and method for quantitatively detecting dysentery amoeba | |
CN116377093A (en) | Method for detecting plasmid copy number in escherichia coli |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |